Government Trades

Overview
Securities
Members
States
Chambers
Committees
Parties

Alnylam Pharmaceuticals Inc

(NASDAQ:ALNY)
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.

top performing ALNY trades

Josh Gottheimer headshot
Josh Gottheimer
House (D-NJ)
45.00%
Daniel Goldman headshot
Daniel Goldman
House (D-NY)
30.60%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Alnylam Pharmaceuticals trades made by congress members.
Josh GottheimerHouse (D-NJ)
$1K - $15KstockSaleFeb 15, 2024Jan 29, 2024
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockPurchaseFeb 15, 2024Jan 11, 2024
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockSaleJan 07, 2024Dec 11, 2023
House
Daniel GoldmanHouse (D-NY)
$15K - $50KstockPurchaseApr 17, 2023Mar 06, 2023
House
Daniel GoldmanHouse (D-NY)
$15K - $50KstockSaleFeb 24, 2023Jan 31, 2023
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockPurchaseOct 16, 2022Sep 28, 2022
House